{
    "name": "lutetium Lu 177 vipivotide tetraxetan",
    "comment": "Rx",
    "other_names": [
        "Pluvicto"
    ],
    "classes": [
        "Radiopharmaceuticals"
    ],
    "source": "https://reference.medscape.com/drug/pluvicto-lutetium-lu-177-vipivotide-tetraxetan-4000287",
    "pregnancy": {
        "common": [
            "Data are not available on use in pregnant females; based on its mechanism of action, can cause fetal harm",
            "No animal studies have been conducted to evaluate its effect on female reproduction and embryo-fetal development; however, all oncology#radiopharmaceuticals have potential to cause fetal harm"
        ],
        "specific": [
            {
                "type": "Contraception",
                "description": [
                    "Based on its mechanism of action, advise male patients with female partners of reproductive potential to use effective contraception during treatment and for 14 weeks after the last dose"
                ]
            },
            {
                "type": "Infertility",
                "description": [
                    "Cumulative dose of 44.4 GBq results in a radiation absorbed dose to the testes within the range that may cause temporary or permanent infertility"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "There are no data on presence in human milk or its effects on breastfed children or milk production "
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Based on its mechanism of action, can cause fetal harm",
                "May cause temporary or permanent infertility in males"
            ],
            "specific": [
                {
                    "type": "Radiation exposure",
                    "description": [
                        "Contributes to patientâ€™s overall long-term cumulative radiation exposure",
                        "Long-term cumulative radiation exposure is associated with increased risk for cancer",
                        "Minimize radiation exposure to patients, medical personnel, and household contacts during and after treatment",
                        "Ensure that patients increase oral fluid intake and advise patients to void as often as possible to reduce bladder radiation",
                        "Before patient is released, explain necessary radioprotection precautions to follow to minimize radiation exposure to others",
                        "Advise patient to limit close contact (<3 feet) with household contacts for 2 days or with children and pregnant women for 7 days",
                        "Advise patient to refrain from sexual activity for 7 days, and to sleep in a separate bedroom from household contacts for 3 days, from children for 7 days, or from pregnant women for 15 days"
                    ]
                },
                {
                    "type": "Myelosuppression",
                    "description": [
                        "My cause severe and life-threatening myelosuppression, including anemia, thrombocytopenia, leukopenia, and neutropenia",
                        "Perform complete blood cell counts before and during treatment",
                        "Withhold, reduce dose, or permanently discontinue and clinically treat patients based on the severity of myelosuppression ",
                        "Advise patients to contact their healthcare provider for any signs or symptoms of myelosuppression (eg, tiredness, weakness, pale skin, shortness of breath, bleeding or bruising more easily than normal, or difficulty to stop bleeding) or frequent infections with signs, such as fever, chills, sore throat, or mouth ulcers "
                    ]
                },
                {
                    "type": "Renal toxicity",
                    "description": [
                        "Can cause severe renal toxicity",
                        "Advise patients to remain well hydrated and to urinate frequently before and after administration",
                        "Perform kidney function laboratory tests, including serum creatinine and calculated CrCl, before and during treatment",
                        "Withhold, reduce dose, or permanently discontinue based on severity of renal toxicity"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Decreased lymphocytes",
            "percent": "85"
        },
        {
            "name": "Decreased hemoglobin",
            "percent": "63"
        },
        {
            "name": "Decreased leukocytes",
            "percent": "56"
        },
        {
            "name": "Decreased platelets",
            "percent": "45"
        },
        {
            "name": "Fatigue",
            "percent": "43"
        },
        {
            "name": "Dry mouth",
            "percent": "39"
        },
        {
            "name": "Decreased calcium",
            "percent": "39"
        },
        {
            "name": "Nausea",
            "percent": "35"
        },
        {
            "name": "Decreased sodium",
            "percent": "33"
        },
        {
            "name": "Anemia",
            "percent": "32"
        },
        {
            "name": "Increased AST",
            "percent": "28"
        },
        {
            "name": "Decreased neutrophils",
            "percent": "28"
        },
        {
            "name": "Increased creatinine",
            "percent": "24"
        },
        {
            "name": "Increased potassium",
            "percent": "24"
        },
        {
            "name": "Decreased appetite",
            "percent": "21"
        },
        {
            "name": "Constipation",
            "percent": "20"
        },
        {
            "name": "Vomiting",
            "percent": "19"
        },
        {
            "name": "Diarrhea",
            "percent": "19"
        },
        {
            "name": "Thrombocytopenia",
            "percent": "17"
        },
        {
            "name": "Urinary tract infection",
            "percent": "12"
        },
        {
            "name": "Weight loss",
            "percent": "11"
        },
        {
            "name": "Abdominal pain",
            "percent": "11"
        },
        {
            "name": "Increased sodium",
            "percent": "11"
        },
        {
            "name": "Decreased lymphocytes",
            "percent": "47"
        },
        {
            "name": "Decreased hemoglobin",
            "percent": "15"
        },
        {
            "name": "Anemia",
            "percent": "13"
        },
        {
            "name": "Peripheral edema",
            "percent": "10"
        },
        {
            "name": "Acute kidney injury",
            "percent": "9"
        },
        {
            "name": "Dizziness",
            "percent": "8"
        },
        {
            "name": "Headache",
            "percent": "7"
        },
        {
            "name": "Dysgeusia",
            "percent": "7"
        },
        {
            "name": "Pyrexia",
            "percent": "7"
        },
        {
            "name": "Decreased platelets",
            "percent": "9"
        },
        {
            "name": "Thrombocytopenia",
            "percent": "8"
        },
        {
            "name": "Decreased leukocytes",
            "percent": "7"
        },
        {
            "name": "Fatigue",
            "percent": "6"
        },
        {
            "name": "Decreased neutrophils",
            "percent": "4.5"
        },
        {
            "name": "Urinary tract infection",
            "percent": "3.8"
        },
        {
            "name": "Acute kidney injury",
            "percent": "3.2"
        },
        {
            "name": "Decreased calcium",
            "percent": "2.5"
        },
        {
            "name": "Decreased appetite",
            "percent": "1.9"
        },
        {
            "name": "Nausea",
            "percent": "1.3"
        },
        {
            "name": "Constipation",
            "percent": "1.1"
        },
        {
            "name": "Abdominal pain",
            "percent": "1.1"
        },
        {
            "name": "Increased AST",
            "percent": "1.1"
        },
        {
            "name": "Weight loss",
            "percent": null
        },
        {
            "name": "Peripheral edema",
            "percent": null
        },
        {
            "name": "Pyrexia",
            "percent": null
        },
        {
            "name": "Vomiting",
            "percent": null
        },
        {
            "name": "Diarrhea",
            "percent": null
        },
        {
            "name": "Dizziness",
            "percent": null
        },
        {
            "name": "Headache",
            "percent": null
        },
        {
            "name": "Decreased sodium",
            "percent": null
        },
        {
            "name": "Increased creatinine",
            "percent": null
        },
        {
            "name": "Increased potassium",
            "percent": null
        }
    ]
}